Showing 1271-1280 of 1742 results for "".
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31171/Thrombolytic therapy for acute ischemic stroke, specifically tissue plasminogen activator (tPA), remains significantly underutilized, with treatment rates persisting below five percent despite robust evidence supporting its efficacy and safety. Since the FDA approved tPA for stroke in 1996, multiple
- Will Subspecialty Certification Change Your View of Neuroimaging?https://practicalneurology.com/diseases-diagnoses/imaging-testing/pn1106-certification-pdf/31245/Neuroimaging Gains Subspecialty Status in NeurologyIn a significant advancement for neurological practice, neuroimaging has been officially recognized as a subspecialty by the United Council of Neurological Subspecialties (UCNS) in July 2006. This designation follows the American Society of Neuroima
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PD0706painmngmt-pdf/31290/Understanding Central Neuropathic Pain: Clinical Insights and Treatment StrategiesCentral neuropathic pain, a challenging subset of chronic pain, arises from lesions within the central nervous system (CNS), including the brain and spinal cord. This pain type is frequently encountered in patients pos
- The Good, the Bad and the Ugly of Alternative Medicinehttps://practicalneurology.com/columns/practice-management/the-good-the-bad-and-the-ugly-of-alternative-medicine/31299/Alternative Medicine in Neurology: Navigating Patient Use and Clinical ImplicationsThe June 2006 issue of *Practical Neurology* addresses the rising prominence of alternative medicine within the neurological patient population, underscored by the bestselling yet controversial book by Kevin Trudeau.
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31026/Recent Advances and Insights in Neurology PracticeReturning to work post-stroke significantly enhances patients' quality of life, yet numerous barriers impede this transition. A study by the George Institute of International Health in Australia examined 1,429 first-time stroke patients, revealing th
- Rethinking the Safety of Stimulants in ADHDhttps://practicalneurology.com/columns/practice-management/rethinking-the-safety-of-stimulants-in-adhd/31322/Cardiovascular Safety of Stimulants in ADHD Treatment: An Update for CliniciansThe use of stimulants in treating Attention-Deficit/Hyperactivity Disorder (ADHD) has long been a cornerstone in managing this pervasive condition, which affects 5-7% of school-aged children and 3-5% of adults. However, r
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0408Epilepsy-pdf/31032/Localization-Related Epilepsy: Insights and Clinical ImplicationsLocalization-related epilepsy (LRE), also known as partial epilepsy, encompasses a spectrum of seizure types including simple partial, complex partial, and secondarily generalized seizures. This condition arises from various etiologies
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31191/Advancements in Neurology: Key Developments in Epilepsy Management and BeyondRecent breakthroughs in epilepsy care are equipping neurologists with enhanced therapeutic options and optimizing existing treatments. A pivotal study published in the April 10th issue of *Neurology* highlights the efficacy
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN1006painmanagement-pdf/31265/Topical Treatments for Musculoskeletal Pain: Efficacy and Safety OverviewIn the October 2006 issue of *Practical Neurology*, Dr. Charles Argoff provides a comprehensive analysis of topical treatments for musculoskeletal pain, focusing on their effectiveness and safety. As interest among clinicians g
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0506epilepsy-pdf/31313/Status Epilepticus: Urgent Management and Clinical InsightsStatus epilepticus (SE) is recognized as a critical neurological emergency requiring immediate intervention to prevent permanent neurological damage or mortality. SE is characterized by seizures lasting more than 30 minutes or recurrent seiz